Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2016-12-05 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于修订公司章程的公告
Governance Information Classification · 95% confidence The document is an announcement from the board of directors of Kunming Pharmaceutical Group Co., Ltd. regarding the revision of the company's articles of association. It details specific changes to the company's charter related to profit distribution policies and voting rights protections for minority shareholders. The announcement states that the proposal was approved by the board and will be submitted to the next shareholders' meeting for approval, with the meeting details to be determined. The document is short (780 characters) and serves as a formal notice of a governance-related change proposal, not the actual governance report or the full amended charter. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2016-12-05 Chinese
八届二十三次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details the decisions made at the 23rd meeting of the 8th Board of Directors, including approval of an investment and a proposal to amend the company's articles of association. The document includes voting results and mentions that the amendment proposal will be submitted to the next shareholders' meeting. There is no financial data or detailed report content, only board meeting decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2016-12-05 Chinese
公司章程（2016年12月修订）
Governance Information Classification · 100% confidence The document is titled '昆药集团股份有限公司章程' which translates to 'Articles of Association of KPC Pharmaceuticals, Inc.' It is a detailed corporate charter or bylaws document, covering company organization, shareholder rights, board structure, capital structure, and governance rules. It includes sections on shares, shareholder meetings, board of directors, senior management, audit, financial accounting, and amendments to the articles. The document is lengthy (15,000 characters) and contains detailed governance and organizational rules rather than financial results or meeting announcements. It is not an annual report, earnings release, or meeting materials. It is a governance document outlining internal rules and company structure. Therefore, the appropriate classification is Governance Information (CGR).
2016-12-05 Chinese
2016年第五次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as the "2016 Fifth Extraordinary General Meeting (EGM) Meeting Materials" of KPC Pharmaceuticals, Inc. It contains detailed meeting agenda, voting procedures, and two specific proposals for shareholder approval regarding the use of idle funds and idle raised funds for investment and cash management. The content is focused on the meeting materials provided to shareholders for the EGM, including explanations of the proposals and voting methods. There are no financial statements or quarterly/yearly financial results presented, nor is this a transcript of a call or a report publication announcement. The document is clearly the meeting materials for a shareholders' meeting, which fits the definition of AGM Information (AGM-R), as it is the presentation and materials shared during a general meeting (in this case, an extraordinary general meeting). The length (8065 characters) and detailed content support this classification with high confidence.
2016-11-29 Chinese
八届十一次监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of Kunming Pharmaceutical Group Co., Ltd. It details voting results on investment and cash management proposals. The content is about board/management decisions and meeting outcomes, not a full report or financial statement. It is not an annual report, audit report, earnings release, or any other financial report type. It is also not a notice of voting results from a shareholder meeting but rather a supervisory board meeting resolution announcement. The closest fitting category is Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management bodies.
2016-11-27 Chinese
八届二十二次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details decisions made at the 22nd meeting of the 8th board of directors, including approvals of investment agreements and proposals to be submitted to the shareholders' meeting. The document includes voting results and references to other announcements but does not contain financial statements or detailed financial data. It is not an annual or interim report, nor a call transcript or earnings release. It is not a report publication announcement since it contains substantive content of board decisions. The document fits best under Board/Management Information (MANG) as it announces board meeting resolutions and decisions.
2016-11-27 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.